How to use Technology Searches
The ‘Technologies Searched’-section displays profiles of unmet needs covering a broad spectrum from scientific expertise to clinical stage product candidates. Text search allows the use of phrases not yet part of our category lists. Key words can be used in combination and help identifying the hits most relevant for you.
A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection “Biomedicine, Diagnostics” in ‘Sector’, “Cancerous, neoplasmatic” in ‘Disease Category, “Drugs, Small Molecule” in ‘Technology’ and “Preclinical” in ‘Development Stage. Selection of “Enabling Technology, Platform technology” in ‘Sector’ will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.
Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee. Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.
Summary
BioXell is looking for urology, inflammation, gynecology, and gastrointestinal therapeutic candidates
Organization name
BioXell SpA
Profile
BioXell is an Italian biopharmaceutical company developing innovative drug candidates for unmet medical needs in urology, inflammation and other selected areas.
BioXell’s lead compound, Elocalcitol, is emerging as a potential new first-line monotherapy for lower urinary tract disorders, with a unique profile of action on the bladder and prostate and an outstanding safety record. BXL746, also derived from the Vitamin D3 class of compounds in which the Company has world-leading expertise, has generated highly positive preclinical data in the widespread and underserved indication post-surgical adhesions.
BioXell seeks to build a diversified and well balanced product portfolio through in-house research and development as well as in-licensing and/or product acquisition in its core business areas:
- urology
- gynecology
- women's health
- inflammation
- gastrointestinal disorders
- pain.
Additional information is provided online.
URL
http://www.bioxell.comYour Feedback
back